Ajax-Loading

Merck & Company Inc - Begin Period Cashflow

Merck & Company Inc's Fiscal Year is From January To December - All Figures are in USD, Billions.

The item "Begin-Period-Cashflow" stands at 44.81 Billion United States Dollars for the trailing twelve months (TTM) period ending 09/30/2025.

Merck & Company Inc's third quarter result of 8.07 Billion USD for the item "Begin Period Cashflow" represents a decrease of -7.55 percent compared to it's second quarter result.

Also, Merck & Company Inc's third quarter result of 8.07 Billion USD for the item "Begin Period Cashflow" represents a decrease of -29.02 percent compared to it's third quarter result of last year.

Looking again at the trailing twelve months series (TTM), Merck & Company Inc's third quarter result of 44.81 Billion USD for the item "Begin Period Cashflow" represents a decrease of -6.86 percent compared to it's second quarter result.


Regarding the One-Year-Change of the series, the current value constitutes an increase of 37.47 percent compared to the value the year prior.
The 1 year change in percent is 37.47.
The 3 year change in percent is 22.50.
The 5 year change in percent is 23.07.
The 10 year change in percent is 32.92.

The Serie's long term average value is 39.50 Billion United States Dollars. It's latest available value, on 09/30/2025, is 13.45 percent higher, compared to it's long term average value.
The Serie's change in percent from it's minimum value, on 12/31/2018, to it's latest available value, on 09/30/2025, is +88.90%.
The Serie's change in percent from it's maximum value, on 12/31/2012, to it's latest available value, on 09/30/2025, is -28.07%.

Begin Period Cashflow for Related Companies:

LogoNameMarket Cap (USD)
LogoEli Lilly and Company - Begin Period Cashflow905,699,262,464.00
LogoJohnson & Johnson - Begin Period Cashflow486,508,953,600.00
LogoAbbVie Inc - Begin Period Cashflow399,570,305,024.00
LogoRoche Holding AG - Begin Period Cashflow317,433,206,677.55
LogoAstraZeneca PLC - Begin Period Cashflow280,205,508,085.11